8CPA
Close PBS claims for ACSS payments
Deadline looms for final ACSS bulk manual payment cycle claims Pharmacists are being urged to close Pharmaceutical Benefits Scheme (PBS) claims to ensure Additional Community Support Supply (ACSS) payments can be made. In …
Fee hikes for pharmacy
Pharmacies are set to benefit from indexed increases to components of the Commonwealth price from 1 July 2025 Dispensing, dangerous drug and Administration, Handing and Infrastructure (AHI) fees paid to …
Stakeholders meet to sculpt pharmacy services vision
Representatives of more than 20 pharmacy, medical, health practitioner and consumer groups discuss the future of pharmacy services Pharmacist-delivered health programs not funded through the Eighth Community Pharmacy Agreement (8CPA) …
Funding secured for non-8CPA programs
Future of pharmacy programs secured with Department confirming funding beyond 30 June 2025 Funding for a range of pharmacy programs that was set to expire at the end of the …
Funding CSO ‘essential’: NPSA
Talks are continuing to secure new Pharmaceutical Wholesalers’ Agreement to future-proof the CSO More than four months after the government announced that funding for the distribution of medicines through Community …
The flightpath to ‘foolish flying’
With the 8CPA signed off, some in the industry believe the pressure is off, but is that the case? In September 1956, Thomas Fitzpatrick, a private pilot from New York …
Call to end DAA caps
Guild to push for changes to eligibility criteria for dose administration aids Patients should not be deprived access to dose administration aids (DAAs) due to caps on the numbers …
Guild leader seeks council seat
Outgoing Guild branch president plots self-funded bid for local council Fresh from negotiating the Eighth Community Pharmacy Agreement (8CPA), Anthony Tassone is putting his hand up for a seat on …
The Week in Review
Changes to nicotine vaping legislation, the proposed Sigma/Chemist Warehouse merger and pharmacy’s role in encouraging at-risk individuals to access Take Home Naloxone, dominated the headlines this week After a late …
